A method was developed for the quantitation of six eumelanin-related indolic compounds in urine. The procedure employs methane ionization of the hexafluoroisopropyl and/or pentafluoropropionyl derivatives of 5,6-dihydroxyindole, 5-hydroxy-6-methoxyindole, 6-hydroxy-5-methoxyindole, 5-hydroxy-6-methoxyindolyl-2-carboxylic acid, 6-hydroxy-5-methoxyindolyl-2-carboxylic acid and 5,6-dimethoxyindolyl-2-carboxylic acid together with their deuterated analogues, and selected ion-monitoring. Deuterated analogues are added äs internal Standards to enzymatically hydrolysed urine before diethyl ether extraction.
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Introduction
A well known problem in the management of cancer patients is the detection of the clinically occult changes of the disease. Different chemical approaches to these problems have been attempted, particularly in those tumours that exhibit characteristic biochemical features. Since malignant melanocytes usually synthesize melanin, it is not surprising that attention has been paid to the intermediates of the melanin synthesis and their determination in urine and serum of melanoma patients.
The attempts to use the pheomelanin precursor 5-Scysteinyl-DOPA s a tumour marker for malignant melanoma are well known (1) (2) (3) . Much less is known, however, about the possibility of employing eumelanin precursors and their metabolites (eumelanin-related compounds). This group consists of seven indolic substances: 5,6-dihydroxyin,dole, 5-hydroxy-6-methoxyindole, 6-hydroxy-5-methoxyindole, 5,6-dihydroxyindolyl-2-carboxylic acid, 5-hydroxy-6-methoxyindolyl-2-carboxylic acid, 6-hydroxy-5-methoxyindolyl-2-carboxylic acid and 5,6-dimethoxyindolyl-2-carboxylic acid.
Two of them, namely 5-hydroxy-6-methoxyindolyl-2-carboxylic acid and 6-hydroxy-5-methoxyindolyl-2-carboxylic acid, were identified by Duchon & Matous in 1967 (4), the others were described during the last three years (5 -7). Gas chromatography was shown to be a useful technique, providing good Separation of the eumelaninrelated indolic compounds from urine of patients with malignant melanoma (5, 8) . It failed, however, to detect the substances in urine samples of healthy persons, owing to their low concentrations and peak interferences with other compounds. Therefore a more selective technique of detection has been chosen. In this paper we report our flrst experience with a gas Chromatographie mass spectrometric method in chemical ionization mode, which has been used for follow-up of the urinary excretion of eumelanin-related indolic compounds in patients before, during and after cytostatic treatment.
Materials and Methods
Chemicals
Pentafluoropropionic anhydride and 1,1,1,3,3,3-hexafluoroisopropanol were purchased from Pierce Chemical Co., Rockford, IL, U.S. A., Helix pomatia juice was obtained from l'Industrie Biologique Fransaise, Gennevilliers, France. 5,6-Dihydroxyindole, 5-hydroxy-6-methoxyindole, 6-hydroxy-5-methoxyindole, 5-hydroxy-6-methoxyindolyl-2-carboxylic acid, 6-hydroxy-5-methoxyindolyl-2-carboxylic acid, 5,6-dimethoxyindolyl-2-carboxylic acid s well s their deuterium labelled analogues were prepared s described earlier (9) . The compounds were stored s diluted ethyl acetate Solutions at -40 °C under nitrogen, and their actual concentrations were measured shortly before their use by gas chromatography with a flattie^ionization detector. All other chemicals were purchased from Merck, Darmstadt, West Germany.
Patients and treatment
Brief descriptions of the individual cases of the melanoma patients are given in the legends to the figures.
All the patients were treated according to the following five day chemotherapeutic scheme: 
Samples
Twenty four-hour specimens of urine were collected from melanoma patients and from healthy volunteers. Ten ml aliquots were then stored without any preservation at -20 °C until use.
Hydrolysis, extraction and derivatizatiom To 2 ml of urine, 500 μΐ of 2.5 mol/1 sodiuiii acetate buffer pH 6.2 and 100 μΐ of Helix pomatia juice were added. The solution was bubbled with nitrogen, the tubes tightly closed and placed in a shaking water bath at 37 °C for 90 min. To each hydrolysed urine sample, a mixture of home-made deuterium labelled indolic substances (300 μΐ) was added, containing approximately loOpmol 5,6-dihydroxyindole, 890 pmol 5-hydroxy-6-methoxyindole, 400 pmol 6-hydroxy-5-methoxyindole, 560 pmol 5-hydroxy-6-methoxyindolyl-2-carboxylic acid, 190 pmol 6-hydroxy-5-methoxyindolyl-2-carboxylic acid and 60 pmol 5,6-dimethoxyindolyl-2-carboxylic acid. The samples were saturated with NaCl and extracted with 2 χ 4 ml of diethyl ether. Pooled extracts were dried over anhydrous sodium sulphate and evaporated to dryness at 40 °C under a stream of nitrogen.
Derivatization was carried out by the addition of 50 μΐ of hexafluoroisopropanol followed by 100 ul of pentafluoropropionic anhydride. The tubes were then heated in a heating block at 60 °C for 10 min. After evaporation under a stream of nitrogen, the residue was dissolved in 20 μΐ of ethyl acetate containing 5% of pentafluoropropionic anhydride.
Gas chromatography-mass spectrometry + of 5,6-dimethoxyindolyl-2-carboxylic acid(HFIP)-d 8 The position of deuterium atoms in the indole molecules was described earlier (9) .
Results
As shown in figure l, the method used gave a good Separation of all eumelanin-related indolic compounds, which could therefore be measured in a single Chromatographie run. The concentration of each substance was calculated by using its own internal Standard and calibration curve. In the concentration r nge of 0.25 -25 nmol/1, the coefficient of Variation of the method was satisfactory (2.5 -6.0%). However, when normal urine samples and those containing extreme concentrations of indoles were analysed, the coefficient of Variation was found to be higher than 10%. In the latter case, quality control could be improved by prior dilution of urine. The recoveries of individual indolic eumelanin-related compounds added to urine samples before their processing were in the r nge of 80 -120%.
The excretion values of indolic eumelanin-related compounds in four melanoma patients before, during and after the therapy are shown in figures 2-5.
Discussion
Although the group of eumelanin-related indolic sub-, stances consists of seven indolic compounds, it appears that not all of them are suitable for routine laboratory determination. In general, the main eumelanin precursors, namely 5,6-dihydroxyindole and 5,6-dihydroxyindolyl-2-carboxylic acid, are known to readily undergo oxidation and polymerization. Their O-methylation and/or conjugation with sulphate or glucuronate at least partly protect them against the mentioned processes. However, our experience has shown that 5,6-dihydroxyindolyl-2-carboxylic acid is excreted in an unconjugated form and may therefore initiate secondary formation of melanin in melanotic urine during collection and storage. That is why the measured concentration of this substance in urine may not be related solely to its production rate, but may also be dependent on other conditions, such äs pH of the urine or the presence of oxidative or reductive substances. In other words, the instability of this eumelanin precursor would make the Interpretation of its concentration values unreliable. That was the reason why 5,6-dihydroxyindolyl-2-carboxylic acid was not included in our measurements.
Although 5,6-dihydroxyindole is reported to be excreted äs a sulphate conjugate (10), and thus partially protected against polymerization and oxidation, its determination is accompanied by several structurally related difficulties:
(a) the compound is partially oxidized and polyinerized during the hydrolysis, In view of these problems, the determination of 5,6-dihydroxyindole also does not seem to be suitable for routine purposes.
The recently discovered 5,6-dimethoxyindolyl-2-carboxylic acid (7) was present in normal urine in very low, sometimes undetectable amounts. Although this substance is interesting from the biochemical point of view, the small differences in its excretions in normal and melanotic urine (see fig. 2 ) make its determination less useful.
From the foregoing it can be seen that O-methylated indoles are apparently more suitable metabolites for routine measurements because of their relative stability. As shown in the follow-up curves of Ihe melanoma patients, 5-hydroxy-6-methoxyindole consistently exhibited the highest differences between preand post-therapeutic stadia. It appears that this substance is the most sensitive indicator of increased eumelanin production for pigmented malignant melanoma.
5-Hydroxy-6-methoxyindolyl-2-carboxylic acid and 6-hydroxy-5-methoxyindolyl-2-carboxylic acid were found to be excreted in a pathological ränge, pnly if the excretion of the 5-hydroxy-6-methoxyindole was extremely elevated. In other cases, their excretion values were in the normal physiological ränge, so that they have limited value for the detection of the increased eumelanin production. Our measurements also showed a similar excretion of both isomeric acids, so it appears to be sufficient to measure only one of them.
Some patients exhibited a decrease of 5-hydroxy-6-methoxyindole with a temporal overshoot of isomeric 5-hydroxy-6-methoxy-and 6-hydroxy-5-methoxyindolyl-2-carboxylic acid excretion after the treatment (see fig. 5 ). This fact raises the question of whether carboxylic and non-^carboxylic eumelanin-related compounds share the same mode of generation, cell compartmentalization, and exeretion froni the organism. .Further investigations äimed at interpreting the behaviour of each eumelanin-related nietabolite will be necessary. Since the eumelanin-related substances are «pecific inetabolites of melanocytes, it is obvious that their excretion might be dependent on the amount of these melanin-forming cells äs well äs on their metabolic, namely melanogenic activity. That is why the decrease of the excretion of the eumelanin-related indoles after the treatment does not necessarily mean the reduction of the tumour mass, but may only indicate metabolic changes in the cellular metabolism of the melanocytes. The long-term follow-up may show whether these changes are transient or permanent, in other words, whether the treatment was effective. Correlation with clinical picture and repetitive measurements of the eumelanin-related compounds are therefore advisable.
In some cases, the high tumour load is not accompanied by an increased excretion of the eumelaninrelated metabolites (see fig. 5 ). This dissapointing fact can be explained by (a) a low melanogenic activity of the tumour cells and/or by (b) the existence of an alternative mode of excretion of the indolic metabolites (via bile).
A further investigation must be carried out to clarify the real cause of this discrepancy and to shed more light on the Statement, made by Eppinger äs early äs 1910 (11) , that so-called melanogenuria appears only after the development of liver metastases.
